ClinicalTrials.gg
CompletedNCT05248087Updated Feb 21, 2022

Pain, Discomfort, and Functional Impairments During Maxillary Expansion

An interventional study of The bonded McNamara-type appliance and The removable palatal expansion appliance in Constriction, sponsored by Damascus University. Completed at 1 site in Syria. Open to participants aged 12 Years to 16 Years. Per ClinicalTrials.gov, last updated 2022-02-21.

Sponsored by Damascus University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Feb 2020, registered Feb 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
12 Years to 16 Years
Sex
All
01

Study summary

Maxillary expansion is associated with varying degrees of pain and functional impairments. The current study aims to compare rapid maxillary expansion using a McNamara-type (bonded) appliance and slow maxillary expansion using a removable palatal expansion appliance concerning patient-centered outcomes. Those outcomes will include pain and discomfort, mastication difficulties, swallowing difficulties, and pressure on the soft tissues.

Read the detailed description

Skeletal maxillary constriction is one of the common orthodontic problems of all ages, which could be unilateral or bilateral. If it is neglected and not treated, it may result in later orthodontic problems such as skeletal deviation of the lower jaw. The current study aims to use two types of expanders to treat skeletal maxillary constriction in adolescents aged between 12 and 16 years. The study sample will include 52 patients who will be equally divided into two groups: the slow and the rapid maxillary expansion groups. Patients will be asked to answer a questionnaire within five assessment times during the expansion procedure. The questionnaire will contain four questions: 1) What is the degree of discomfort/pain? 2) What is the degree of mastication difficulties? 3) What is the degree of swallowing difficulties? 4) What is the degree of any sense of pressure in soft tissue?

02

Conditions studied

  • Constriction

Keywords

  • Pain
  • Discomfort
  • Crossbite
  • Maxillary expansion
03

In context

Constriction, Pathologic

1,117 studies on the registry are indexed under Constriction, Pathologic; 229 are open to participants now.

This study's enrollment of 52 is below the median of 80 across 671 interventional studies indexed under Constriction, Pathologic.

Browse Constriction, Pathologic studies →

Lead sponsor

Damascus University is the lead sponsor of 210 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Adolescents between 12 and 16 years.
  2. Early permanent dentition.
  3. Skeletal bilateral maxillary constriction.
  4. There is no loss or absence of any permanent teeth except for the third molar.
  5. Dental and skeletal class I/II malocclusion.
  6. Normal/mild vertical growth pattern.

Exclusion criteria

Exclusion Criteria:

  1. Previous orthodontic treatment.
  2. A severe horizontal growth pattern.
  3. Any periodontal diseases.
  4. Any general diseases or syndromes.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (actual)

Study arms

  • Experimental
    The rapid maxillary expansion

    The rapid maxillary expansion will be applied using a McNamara-type (bonded) appliance.

    Device: The bonded McNamara-type appliance

  • Active comparator
    The slow maxillary expansion

    The slow maxillary expansion will be applied using a removable palatal expansion appliance.

    Device: The removable palatal expansion appliance

Interventions

  • DeviceThe bonded McNamara-type appliance

    The patient will be asked to expand twice a day until obtaining an overcorrection of 2-3 mm. Then the expander will be kept in place for three months as a retention period.

  • DeviceThe removable palatal expansion appliance

    The slow maxillary expansion will be applied using a removable palatal expansion appliance with a midline screw. The patient will be asked to expand twice a week until obtaining an overcorrection of 2-3 mm.

06

What researchers measure

Primary outcomes

  1. Change in the levels of discomfort or pain

    The degree of pain and discomfort that patients feel will be determined using their answers to the following question (question 01): 'What is the degree of discomfort/pain?' The Visual Analogue Scale (VAS) will be adopted to measure the degree of discomfort/pain.

    Time frame: T1: after 24 hours; T2: on the 7th day; T3: on the 15th day; T4: after 1 month; T5: after 4 months

  2. Change in the levels of mastication difficulties

    The degree of mastication difficulties that patients feel will be determined using their answers to the following question (question 02): 'What is the degree of mastication difficulties?' The Visual Analogue Scale (VAS) will be adopted to measure the degree of mastication difficulties.

    Time frame: T1: after 24 hours; T2: on the 7th day; T3: on the 15th day; T4: after 1 month; T5: after 4 months

  3. Change in the levels of swallowing difficulties

    The degree of swallowing difficulties that patients feel will be determined using their answers to the following question (question 03): ' What is the degree of swallowing difficulties?' The Visual Analogue Scale (VAS) will be adopted to measure the degree of swallowing difficulties.

    Time frame: T1: after 24 hours; T2: on the 7th day; T3: on the 15th day; T4: after 1 month; T5: after 4 months

  4. Change in the levels of sensation of pressure on soft tissue

    The degree of any sense of pressure in soft tissue that patients feel will be determined using their answers to the following question (question 04): ' What is the degree of any sense of pressure in soft tissue? ' The Visual Analogue Scale (VAS) will be adopted to measure the degree of any sense of pressure in soft tissue.

    Time frame: T1: after 24 hours; T2: on the 7th day; T3: on the 15th day; T4: after 1 month; T5: after 4 months

07

Study locations

1 site
  • University of Damascus
    Damascus, Syria
08

References and documents

Publications

  • Saleh M, Hajeer MY, Al-Jundi A. Assessment of pain and discomfort during early orthodontic treatment of skeletal Class III malocclusion using the Removable Mandibular Retractor Appliance. Eur J Paediatr Dent. 2013 Jun;14(2):119-24. PubMed 23758461 ↗
  • Halicioglu K, Kiki A, Yavuz I. Subjective symptoms of RME patients treated with three different screw activation protocols: a randomised clinical trial. Aust Orthod J. 2012 Nov;28(2):225-31. PubMed 23304972 ↗
  • Feldmann I, Bazargani F. Pain and discomfort during the first week of rapid maxillary expansion (RME) using two different RME appliances: A randomized controlled trial. Angle Orthod. 2017 May;87(3):391-396. doi: 10.2319/091216-686.1. Epub 2016 Dec 28. PubMed 28029266 ↗
  • Ugolini A, Cossellu G, Farronato M, Silvestrini-Biavati A, Lanteri V. A multicenter, prospective, randomized trial of pain and discomfort during maxillary expansion: Leaf expander versus hyrax expander. Int J Paediatr Dent. 2020 Jul;30(4):421-428. doi: 10.1111/ipd.12612. Epub 2020 Jan 20. PubMed 31894603 ↗
  • De Felippe NL, Da Silveira AC, Viana G, Smith B. Influence of palatal expanders on oral comfort, speech, and mastication. Am J Orthod Dentofacial Orthop. 2010 Jan;137(1):48-53. doi: 10.1016/j.ajodo.2008.01.023. PubMed 20122430 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2020 to primary completion in Mar 2021, 13 months.

Of 201 non-industry interventional studies with no phase under Constriction, Pathologic, half reached primary completion within 41 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 59. This study's 13 months is below that.

Counting every sponsor, half of 287 studies reached it within 36 months; a quarter within 19 and three quarters within 59.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 10, 2022
First posted
Feb 21, 2022
StartActual
Feb 20, 2020
Primary completionActual
Mar 20, 2021
CompletionActual
Jul 25, 2021
Last update
Feb 21, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05248087
Responsible party
Sponsor
First posted
Feb 21, 2022
Start date
Feb 20, 2020
Primary completion
Mar 20, 2021
Completion
Jul 25, 2021
Last update
Feb 21, 2022

Study contacts

Nancy Rabah, DDS,MSc
principal investigator · Specialist and Clinical Lecturer, Department of Orthodontics, University of Damascus
Heba M Al-Ibrahim, DDS,MSc
principal investigator · Specialist and Clinical Lecturer, Department of Orthodontics, University of Damascus
Mohammad Y Hajeer, DDS,MSc,PhD
study chair · Professor of Orthodontics, University of Damascus Dental School, Damascus, Syria
Rashad M.T. Murad, DDS,MSc,PhD
study chair · Professor of Pharmaceutics, University of Damascus, Faculty of Pharmacology, Damascus, Syria.

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion